Dr. Volkmar Weissig

Sc.D., Ph.D. ( Dr. rer. nat. habil. )

Professor of Pharmacology (Tenured), College of Pharmacy

Professor of Biomedical Sciences, College of Graduate Studies



  • Ordinary Member European Academy of Science and Arts
  • Invited Member Berlin Scientific Society (BWG)
  • Editor-in-Chief, Journal Liposome Research
  • Editor-in-Chief, Journal Mitochondria, Plastids & Endosymbiosis
  • President World Mitochondria Society
  • Partner at MitochondriaWorldTM
  • SAB Chair MytoLyfe Bio Therapeutics
  • Scientific Advisor MitoCure Foundation
  • Member Editorial Board Life Sciences – Medicine 4Open

Volkmar Weissig, Sc.D., Ph.D. (Dr.rer.nat.habil.) is a Tenured Professor of Pharmacology and Pharmaceutical Sciences, and he holds a second non-tenured appointment as Professor of Biomedical Sciences. Dr. Weissig received his B.S., M.S. and Ph.D. degrees in Chemistry and his postdoctoral Sc.D. degree (habilitation) in Biochemistry and Pharmaceutical Biotechnology from the Martin-Luther University in Halle (Germany). Combined he completed several years of postdoctoral fellowships at the Cardiology Research Center in Moscow (Russia), at the Academic Department of Medicine at the Royal Free Hospital School of Medicine in London (UK), at the Institute of Organic Chemistry at the Czechoslovakian Academy of Science in Prague (CSFR), at the College of Pharmacy and the College of Medicine at the University of Florida, Gainesville, FL and at Harvard Medical School and Massachusetts General Hospital in Boston, MA. Before joining the faculty at Midwestern University, Dr. Weissig was an Assistant Professor of Pharmaceutical Sciences at Northeastern University in Boston, MA. Dr. Weissig holds 16 patents, and he has published over 100 research papers, review articles and book chapters, mostly in the area of nano drug delivery systems and mitochondrial medicine. He also edited and published 11 books. He serves as the Editor-in-Chief of the Journal of Liposome Research, the Editor-in-Chief of the Journal of Mitochondria, Plastids and Endosymbiosis, he is also member of several other Editorial Boards among them for 4Open. In July 2009 he was inducted into the World Technology Network as a Fellow. In October 2014 Dr. Weissig was elected President of the World Mitochondria Society. In April 2023 he was elected as Ordinary Member of the European Academy of Science and Arts. In June 2023 he was appointed as Chair of the Scientific Advisory Board of MytoLyfe Biotherapeutics.

Dr. Volkmar Weissig is a Member of the Faculty of THE HEALTH CAPTAINS INSTITUTE (THCI) for Healthy Longevity with his scientific background in Mitrochondrial Health Sciences.